Criterion | Rationale | Assessment | Administered By |
---|---|---|---|
Age 18–65, inclusive. | Defines study population. | Demographics | RA/RC |
Current diagnosis of moderate or severe Cocaine or Methamphetamine Use Disorder (CcUD/MtUD). | Allows for detection of rTMS versus sham effects that may not be apparent with mild CcUD or MtUD. | DSM-5 Checklist– Substance Related Disorders | RA/RC |
Have used cocaine or methamphetamine on at least 10 of the last 30 days. | Emphasizes having a current CcUD or MtUD. | TLFB | RA/RC |
Be willing to decrease cocaine and/or methamphetamine use, but not engaged in formal SUD treatment. | Individuals should have some motivation to attend rTMS sessions (i.e., desire to cut back or quit); however, engagement in formal treatment could confound any study treatment effects. | Treatment Status Form | RA/RC |
Be able to speak English sufficiently. | To comply with ethical standards, and to understand the study procedures, risks, and benefits and provide written informed consent to participate in the study. | Consent Document and Consent Comprehension Tool | RA/RC |
If prescribed benzodiazepines or anticonvulsants, must be on a stable dose for at least 4 weeks prior to consent. | These medications can affect seizure threshold and interfere with the efficacy of rTMS. | Prior and Concomitant Medications; Medical and Psychiatric History | RA/RC/MC; MC |